Asro

A Beacon of Resilience: WHO Director-General’s State Visit to Jordan Highlights Global Health Leadership

• Breast Cancer Prevention and Lifestyle

A Beacon of Resilience: WHO Director-General’s State Visit to Jordan Highlights Global Health Leadership

Asro August 1, 2026

AMMAN, Jordan – The Director-General of the World Health Organization (WHO), Dr. Tedros Adhanom Ghebreyesus, concluded the...

Read More Read more about A Beacon of Resilience: WHO Director-General’s State Visit to Jordan Highlights Global Health Leadership

A New Frontier in Medicine: CRISPR-Based Gene Therapy Casgevy Approved for NHS Patients

• Genomics and Precision Medicine

A New Frontier in Medicine: CRISPR-Based Gene Therapy Casgevy Approved for NHS Patients

Asro July 31, 2026

The landscape of modern medicine has undergone a seismic shift. For decades, individuals suffering from severe, inherited...

Read More Read more about A New Frontier in Medicine: CRISPR-Based Gene Therapy Casgevy Approved for NHS Patients

A Decade of Hope: Landmark Penn Medicine Study Suggests Potential Cures for B-Cell Lymphoma Through CAR T-Cell Therapy

• Clinical Oncology Education

A Decade of Hope: Landmark Penn Medicine Study Suggests Potential Cures for B-Cell Lymphoma Through CAR T-Cell Therapy

Asro July 31, 2026

In a medical landscape often defined by incremental progress, a decade-long study from the Abramson Cancer Center...

Read More Read more about A Decade of Hope: Landmark Penn Medicine Study Suggests Potential Cures for B-Cell Lymphoma Through CAR T-Cell Therapy

Bridging the Gap: Canada Establishes First National Standards for Breast Cancer Care

• Patient Advocacy and Support

Bridging the Gap: Canada Establishes First National Standards for Breast Cancer Care

Asro July 31, 2026

For decades, the Canadian healthcare landscape has been characterized by a "postal code lottery"—a system where the...

Read More Read more about Bridging the Gap: Canada Establishes First National Standards for Breast Cancer Care

Data as a Lifeline: METAvivor Urges Congress to Bolster National Cancer Registries for 2027

• Metastatic Breast Cancer Research

Data as a Lifeline: METAvivor Urges Congress to Bolster National Cancer Registries for 2027

Asro July 30, 2026

In the high-stakes battle against cancer, data is not merely a collection of statistics—it is the frontline...

Read More Read more about Data as a Lifeline: METAvivor Urges Congress to Bolster National Cancer Registries for 2027

FDA Approves Gedatolisib (Revtorpyk) for Advanced HR-Positive/HER2-Negative Breast Cancer: A New Paradigm in Overcoming Endocrine Resistance

• Patient Advocacy and Support

FDA Approves Gedatolisib (Revtorpyk) for Advanced HR-Positive/HER2-Negative Breast Cancer: A New Paradigm in Overcoming Endocrine Resistance

Asro July 30, 2026

The landscape of metastatic breast cancer treatment has undergone a significant transformation with the recent U.S. Food...

Read More Read more about FDA Approves Gedatolisib (Revtorpyk) for Advanced HR-Positive/HER2-Negative Breast Cancer: A New Paradigm in Overcoming Endocrine Resistance

From Hereditary Risk to Healthcare Empowerment: The Transformative BRCA2 Journey of Joanna Lackaye

• Patient Advocacy and Support

From Hereditary Risk to Healthcare Empowerment: The Transformative BRCA2 Journey of Joanna Lackaye

Asro July 30, 2026

By News Desk Updated: June 22, 2026 The intersection of genetics, family history, and preventative medicine has...

Read More Read more about From Hereditary Risk to Healthcare Empowerment: The Transformative BRCA2 Journey of Joanna Lackaye

Biotech Market Pulse: Regulatory Hurdles, Alzheimer’s Breakthroughs, and Strategic Mergers

• Chemotherapy and Targeted Therapy

Biotech Market Pulse: Regulatory Hurdles, Alzheimer’s Breakthroughs, and Strategic Mergers

Asro July 30, 2026

The biotechnology sector experienced a volatile week of trading and clinical updates, characterized by a sharp divide...

Read More Read more about Biotech Market Pulse: Regulatory Hurdles, Alzheimer’s Breakthroughs, and Strategic Mergers

Closing the Data Gap: METAvivor Spearheads Push for Modernized Cancer Registries

• Metastatic Breast Cancer Research

Closing the Data Gap: METAvivor Spearheads Push for Modernized Cancer Registries

Asro July 30, 2026

In the fight against cancer, data is often described as the compass that guides clinical research, drug...

Read More Read more about Closing the Data Gap: METAvivor Spearheads Push for Modernized Cancer Registries

The Invisible Link: Why BRCA Is Not Just a Women’s Health Issue

• Survivorship and Post-Treatment

The Invisible Link: Why BRCA Is Not Just a Women’s Health Issue

Asro July 27, 2026

By [Your Name/Journalistic Staff] June 01, 2026 For decades, the public consciousness surrounding BRCA mutations—specifically BRCA1 and...

Read More Read more about The Invisible Link: Why BRCA Is Not Just a Women’s Health Issue